|
CN101904836A
|
|
New usage of formononetin-3'-sodium sulfonate
|
|
CN101919836A
|
|
New application of rosmarinic acid
|
|
CN101919868A
|
|
Application of forsythoside B
|
|
CN101675934A
|
|
New use of saponins X of dipsacus asperoides
|
|
CN101637474A
|
|
New application of asperosaponin VI
|
|
CN101289438A
|
|
3-(3'-hydroxyl)-butyl phthalide ester, and preparation thereof and uses
|
|
CN102329353A
|
|
Method for preparing morroniside
|
|
CN101385735A
|
|
Pharmaceutical use of morroniside
|
|
CN101342274A
|
|
Curculigo orchioides extract, preparation method and uses thereof
|
|
CN101167707A
|
|
New use of protocatechuic aldehyde
|
|
CN101152200A
|
|
Application of astilbin in preparing medicament for treating or preventing acute and chronic renal failure and renal fibrosis
|
|
CN101897716A
|
|
Application of astilbin in preparing drugs capable of curing or preventing acute renal failure
|
|
CN101134040A
|
|
Application of forsythiaside in the preparation of medicament for treating or preventing acute and chronic liver damnification and liver fibrosis
|
|
CN101134031A
|
|
Use of arctigenin in the preparation of medicament for treating and preventing chronic renal failure and kidney fibrosis
|
|
CN101120965A
|
|
Application of 20(S)-ginsenoside Rh2 in preparing medicine for reducing cardiotoxicity caused by doxorubicin
|
|
CN101112369A
|
|
Application of tanshinol in the preparation of medicine for treating and preventing chronic renal failure and kidney fibrosis
|
|
CN101919837A
|
|
Application of rosmarinic acid in preparing medicament for treating or preventing renal fibrosis
|
|
CN101073568A
|
|
Use of medicine for treating or preventing heart failure
|
|
CN1955171A
|
|
Method for preparing red-rooted salvia phenolic acid B
|
|
CN1951892A
|
|
Preparation method of protocatechualdehyde
|
